Walleye Capital
PMVP icon

Walleye Capital’s PMV Pharmaceuticals PMVP Stock Holding History

Walleye Capital’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$450K Hold
335,694
– – ﹤0.01% 2843
2026
Q1 		$416K Hold
335,694
– – ﹤0.01% 2801
2025
Q4 		$420K Buy
335,694
+57,235
+21% +$76.7K ﹤0.01% 3063
2025
Q3 		$390K Buy
278,459
+200,572
+258% +$277K ﹤0.01% 2808
2025
Q2 		$82.6K Sell
77,887
-23,809
-23% -$23.4K ﹤0.01% 3857
2025
Q1 		$111K Sell
101,696
-25,930
-20% -$35.2K ﹤0.01% 3578
2024
Q4 		$193K Sell
127,626
-18,111
-12% -$28.7K ﹤0.01% 3784
2024
Q3 		$217K Hold
145,737
– – ﹤0.01% 3946
2024
Q2 		$236K Buy
145,737
+95,072
+188% +$171K ﹤0.01% 4180
2024
Q1 		$86.1K Buy
50,665
+267
+0.5% +$499 ﹤0.01% 4467
2023
Q4 		$156K Buy
+50,398
New +$133K ﹤0.01% 3817
2023
Q3 		– Sell
-11,471
Closed -$71.8K – 5225
2023
Q2 		$71.8K Sell
11,471
-44,472
-79% -$233K ﹤0.01% 3536
2023
Q1 		$267K Buy
+55,943
New +$394K ﹤0.01% 2218

Other funds holding PMVP

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AWM
Accurate Wealth Management Wesley Chapel, Florida $1.05B AUM 30.92% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Walleye Capital's PMVP Position: Q2 2026 in Review

Walleye Capital held its PMV Pharmaceuticals (PMVP) position steady in Q2 2026 at 335,694 shares worth $450K. The position accounts for ﹤0.01% of the portfolio, ranked #2843.

Walleye Capital first reported a position in PMVP in Q1 2023 and has held it in 13 quarters since. 5 funds tracked by Wall St. Rank hold PMVP as of Q2 2026.

  • Walleye Capital held 335,694 shares of PMV Pharmaceuticals worth $450K as of Q2 2026.
  • Walleye Capital left its PMV Pharmaceuticals share count unchanged in Q2 2026.
  • PMV Pharmaceuticals made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #2843 holding.
  • Walleye Capital first reported a position in PMV Pharmaceuticals in Q1 2023 and has held it in 13 quarters since.
  • 5 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.